Skip to content
★ Sign in to follow
에스

에스알바이오텍 Stock: price and insider trades · South Korea

No insider purchase over the last 90 days. The latest, by 이소형, was filed 13 Feb 2026.

에스알바이오텍: what insiders have been doing

에스알바이오텍, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 10 November 2026, brought 1 filing signed by 1 insider.

No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. No amount is published for 1 filing, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 2,648 companies we follow on the same exchange. The full history, which starts in 2021, counts 11 purchases against 2 sales.

The most recent open-market purchase was published on 13 February 2026, 270 days ago.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.

Insider Decl.
13
Thresholds
n/a
Buy Volume
n/a
11 ops. · all time
Sell Volume
n/a
2 ops. · all time

Who traded when

BuySale
김아리1 buy
이소형1 buy

Financial data

· cache

Last declaration on 13 February 2026
Declarations13 total
  • ▲
    Executives
    0DART
    897,572 sharesKRXDART:20260213002479
    Canonical exit: 10 May 2026 (T+90)
  • ▲
    Executives(filed)
    0DART
    8,068 sharesShareKRXDART:20250804000183
    Canonical exit: 2 Nov 2025 (T+90)
  • ▼
    -Executives
    0DART
    ShareKRXDART:20240701000145
  • ▼
    Executives
    0DART
    244,802 sharesKRXDART:20240701000143
  • ▲
    Related company / holdingExecutives
    0DART
    ShareKRXDART:20240626000094
    Canonical exit: 22 Sept 2024 (T+90)
  • ▲
    Executives
    0DART
    250,000 sharesKRXDART:20240625000335
    Canonical exit: 12 Sept 2024 (T+90)
  • ▲
    Related company / holdingExecutives
    0DART
    290,507 sharesKRXDART:20240620000087
    Canonical exit: 16 Sept 2024 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    290,507 sharesKRXDART:20221220000140
    Canonical exit: 20 Mar 2023 (T+90)
  • ▲
    Executives(filed)
    0DART
    71,570 sharesKRXDART:20220314000570
    Canonical exit: 12 Jun 2022 (T+90)
  • ▲
    Executives
    0DART
    71,570 sharesShareKRXDART:20220314000575
    Canonical exit: 2 Jun 2022 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    290,507 sharesKRXDART:20210720000245
    Canonical exit: 18 Oct 2021 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    290,507 sharesKRXDART:20210510000461
    Canonical exit: 8 Aug 2021 (T+90)
  • ▲
    Related company / holdingExecutives(filed)
    0DART
    290,507 sharesKRXDART:20210409002010
    Canonical exit: 8 Jul 2021 (T+90)

13 of 13 declarations

About 에스알바이오텍

Listed on the XKRX market, SR Biotech specializes in the health and pharmaceutical sector. The company focuses on developing innovative biopharmaceutical solutions.